Inhibition of the ubiquitin-proteasome system induces stress granule formation

Rachid Mazroui1, Sergio Di Marco, Randal J Kaufman

  • 1McGill University, Department of Biochemistry, Montreal, Quebec, Canada.

Insights

Proteasome inhibition in cancer therapy stabilizes AU-rich element (ARE) mRNAs by forming stress granules (SGs). These stress granules temporarily halt mRNA decay, offering a new therapeutic target.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Proteasome inhibition is a cancer treatment strategy.
  • The effect of proteasome inhibition on AU-rich element (ARE) mRNA decay is not well understood.

Purpose of the Study:

  • To investigate the cellular mechanisms linking proteasome inhibition, stress granule formation, and mRNA metabolism.
  • To elucidate the role of stress granules in the cellular response to proteasome inhibitors.

Main Methods:

  • Studied the ubiquitin-dependent proteasome system (UPS) inhibition.
  • Investigated the formation and disassembly of cytoplasmic stress granules (SGs).
  • Analyzed mRNA metabolism, including the recruitment and stabilization of ARE-containing mRNAs like p21(cip1) mRNA.

Main Results:

  • UPS inhibition leads to the formation of stress granules (SGs) dependent on eIF2alpha phosphorylation via GCN2.
  • SGs formation coincides with processing body (PB) disassembly.
  • ARE-containing mRNAs are recruited to and stabilized within SGs.
  • Prolonged UPS inhibition causes SG disassembly and translation recovery, dependent on Hsp72.

Conclusions:

  • Stress granules (SGs) play a role in the early cellular response to proteasome inhibitors.
  • SGs temporarily interfere with mRNA decay pathways, stabilizing ARE-mRNAs.
  • This mechanism highlights a novel aspect of cancer therapy involving proteasome inhibition and mRNA regulation.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...